GET DAILY SIGNALSMondelēz International (MDLZ) Posts Q3 Beat as Volumes Turn Positive
Key Takeaways
- Adjusted earnings per share (EPS) of $0.78 beat the consensus estimate of roughly $0.71, while net revenue of $9.97 billion was essentially in line with expectations.
- Net revenue rose 2.3% year over year, with organic revenue up 2.1%, driven by 1.8% volume/mix growth and 0.3% pricing.
- GAAP diluted EPS jumped 78.9% to $1.02, reflecting improved commodity cost dynamics and a favorable year-over-year comparison.
- Adjusted operating income margin expanded 190 basis points to 13.9%, helped by lower raw material costs and productivity gains.
- Management reaffirmed its full-year 2026 outlook, including at least 2% organic revenue growth and adjusted EPS growth of flat to 5% on a constant-currency basis.
- Shares rose about 3.2% in after-hours trading following the release.
- For more detail on MDLZ, you can explore additional pages covering Major News, Today's Price Move, Price Targets, and Forecasts.
Why These Results Matter Now
Mondelēz International's third-quarter 2026 results come at an important time for the global snacking company. After periods where price hikes had hidden softer volumes, investors have been looking for signs that consumers are coming back to core biscuit and chocolate brands. The quarter also stands out because of elevated cocoa costs that have squeezed margins industry-wide. A shift back toward volume-driven growth, rather than price-led gains, would point to healthier underlying demand and bolster confidence in the sustainability of earnings across both developed and emerging markets.
The Quarter in Detail
MDLZ reported third-quarter 2026 net revenue of $9.97 billion, up 2.3% year over year and roughly matching Wall Street expectations. Organic net revenue increased 2.1%, supported by a 1.8% rise in volume/mix and a 0.3% contribution from pricing. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Adjusted EPS reached $0.78, topping the consensus estimate of about $0.71 by around 10% and advancing 5.5% on a constant-currency basis. On a GAAP basis, diluted EPS climbed 78.9% to $1.02, aided by lower raw material costs and an easier comparison with the prior year.
Adjusted operating income margin widened 190 basis points to 13.9%, while GAAP operating margin improved to 17.6% from 7.6% a year earlier. Regionally, Latin America posted the strongest growth with net revenue up 12.0%, Asia, Middle East & Africa rose 8.2%, Europe fell 3.3%, and North America gained 1.1%. For fiscal 2026, the company kept its guidance for at least 2% organic net revenue growth, adjusted EPS growth of flat to 5% on a constant-currency basis, and roughly $3 billion in free cash flow.
How the Market Reacted
Shares of MDLZ climbed about 3.2% in after-hours trading. The move reflected relief that volume/mix had returned to growth after an extended period of declines, along with the solid adjusted EPS beat. Investors also welcomed the margin expansion, which showed the company could translate steady top-line performance into better profitability despite ongoing cocoa cost pressures. The combination of in-line revenue and an earnings beat driven by cost control reinforced the sense that Mondelēz is managing commodity swings while rebuilding demand.
What to Watch Going Forward
Looking ahead, the key question is whether the return to volume-led growth can continue. The reaffirmed 2026 guidance offers a baseline, but the quality of that growth will matter. Commodity costs remain a focus; while lower raw material expenses and productivity gains helped margins this quarter, cocoa prices stay volatile and any sharp increase could affect the chocolate business. Management’s ability to balance pricing with input costs will be important for profitability.
Regional trends also deserve attention, especially the contrast between solid emerging-market growth and softer results in Europe and North America. Sustaining momentum will likely require ongoing investment in brands, innovation, and distribution while defending share in the portfolio that includes Oreo and Cadbury.
Integrating AI Tools Into My Research
When reviewing earnings like these, I often turn to Tickeron’s AI Screener to quickly filter for comparable companies and spot technical patterns that might influence the stock’s next moves. It helps me cross-check fundamentals against broader market signals without spending hours on manual work.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for MDLZ turns negative, indicating new downward trend
MDLZ saw its Momentum Indicator move below the 0 level on October 28, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned negative. In 57 of the 102 cases, the stock moved further down in the following days. The odds of a decline are at 56%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for MDLZ moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 19 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 46%.
The Moving Average Convergence Divergence Histogram (MACD) for MDLZ turned negative on October 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 25 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
The Aroon Indicator for MDLZ entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
MDLZ moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MDLZ crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +2.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where MDLZ advanced for three days, in 166 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
MDLZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. MDLZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.996) is normal, around the industry mean (1.370). P/E Ratio (22.904) is within average values for comparable stocks, (14.286). Projected Growth (PEG Ratio) (0.891) is also within normal values, averaging (1.364). Dividend Yield (0.033) settles around the average of (0.164) among similar stocks. P/S Ratio (2.028) is also within normal values, averaging (1.937).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of packaged food products
Industry FoodSpecialtyCandy
Advertisement